This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Alain Wagner, PhD
Research Director at CNRS

Profile

Dr. Alain Wagner received a PhD in organic chemistry from Université Louis Pasteur (1991), followed by a post-doctoral fellowship with Prof. Peter Schultz at Affymax Research Institute (1991-1993, Palo Alto, USA). He joined CNRS in 1994 to develop projects dealing with combinatorial approaches in drug discovery. Promoted research director in 2001, Alain Wagner took a sabbatical to found Novalix Pharma (2002-2007). He latter participated actively in the creation of eNovalys (2009) a pioneering company that stake on the digital technology exploiting raw experimental data and AI as a source of innovation. On returning to the CNRS (2008) he took the lead of the BioFunctional Chemistry Lab (www.biofunctional.eu) to investigate xenobiotic synthetic reactivity. Alain has recently co-founded Syndivia SAS, which provides advanced technologies for drug bio-conjugation / drug release (2014). Dr Wagner published more than 150 articles and is an inventor of 22 patents. He is currently is involved in the creation of MicroOmiX Technology a company developing advanced single cell secretomic analytics.

Agenda Sessions

  • Chemical Approaches Toward Antibody-Oligonucleotide Constructs with Optimized Delivery Properties

    On Demand
  • Chemical Approaches Toward Antibody-Oligonucleotide Constructs with Optimized Delivery Properties

    On Demand
  • Oligonucleotide Conjugation Strategies

    12:15